DICHIARA, MARIA
 Distribuzione geografica
Continente #
AS - Asia 2.065
NA - Nord America 1.488
EU - Europa 1.331
SA - Sud America 456
Continente sconosciuto - Info sul continente non disponibili 189
AF - Africa 52
OC - Oceania 1
Totale 5.582
Nazione #
US - Stati Uniti d'America 1.423
SG - Singapore 614
IT - Italia 526
CN - Cina 473
RU - Federazione Russa 466
BR - Brasile 371
VN - Vietnam 274
HK - Hong Kong 215
KR - Corea 166
IN - India 75
FR - Francia 57
BD - Bangladesh 50
JP - Giappone 50
GB - Regno Unito 41
DE - Germania 38
NL - Olanda 35
FI - Finlandia 32
AR - Argentina 31
TW - Taiwan 31
CA - Canada 27
IE - Irlanda 25
MX - Messico 25
AT - Austria 19
ZA - Sudafrica 19
ID - Indonesia 18
IQ - Iraq 14
KE - Kenya 14
ES - Italia 12
IR - Iran 12
UA - Ucraina 12
EC - Ecuador 11
CO - Colombia 10
PL - Polonia 10
AE - Emirati Arabi Uniti 9
PH - Filippine 9
TR - Turchia 9
VE - Venezuela 8
CH - Svizzera 7
CL - Cile 7
PE - Perù 7
PK - Pakistan 7
LT - Lituania 6
PY - Paraguay 6
AL - Albania 4
AZ - Azerbaigian 4
BE - Belgio 4
CI - Costa d'Avorio 4
CZ - Repubblica Ceca 4
KG - Kirghizistan 4
RS - Serbia 4
SA - Arabia Saudita 4
SK - Slovacchia (Repubblica Slovacca) 4
UY - Uruguay 4
UZ - Uzbekistan 4
BY - Bielorussia 3
JM - Giamaica 3
KZ - Kazakistan 3
LB - Libano 3
LV - Lettonia 3
SE - Svezia 3
CR - Costa Rica 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
EE - Estonia 2
EG - Egitto 2
GE - Georgia 2
HN - Honduras 2
HU - Ungheria 2
IL - Israele 2
JO - Giordania 2
MD - Moldavia 2
MK - Macedonia 2
MY - Malesia 2
NI - Nicaragua 2
NP - Nepal 2
TN - Tunisia 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
BW - Botswana 1
CG - Congo 1
CY - Cipro 1
DZ - Algeria 1
ET - Etiopia 1
GA - Gabon 1
GT - Guatemala 1
LA - Repubblica Popolare Democratica del Laos 1
MA - Marocco 1
MU - Mauritius 1
NG - Nigeria 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PT - Portogallo 1
RO - Romania 1
SC - Seychelles 1
SI - Slovenia 1
Totale 5.389
Città #
Dallas 406
Singapore 352
Hefei 226
Hong Kong 169
Seoul 154
Milan 136
Council Bluffs 134
Moscow 134
Santa Clara 119
Ho Chi Minh City 100
Beijing 84
Los Angeles 78
Ashburn 77
San Jose 72
Hanoi 63
Rome 63
Siena 48
Lauterbourg 43
Bengaluru 41
Tokyo 41
The Dalles 37
Florence 36
Chicago 28
São Paulo 26
Buffalo 24
Dublin 24
Columbus 18
Taipei 18
Helsinki 17
Turin 17
Redondo Beach 16
Nuremberg 15
Catania 13
Haiphong 13
Lappeenranta 13
New York 13
Vienna 13
Johannesburg 12
Mexico City 12
Naples 12
Orem 12
Figino 11
Salt Lake City 11
Tehran 11
Rio de Janeiro 10
Bologna 9
Chennai 9
Da Nang 9
Frankfurt am Main 9
Belo Horizonte 8
Lucca 8
Warsaw 8
Amsterdam 7
Baghdad 7
Denver 7
London 7
Montreal 7
Quito 7
Silver Spring 7
Asunción 6
Biên Hòa 6
Curitiba 6
Dobong-gu 6
Lima 6
Manaus 6
Phoenix 6
Phủ Lý 6
Brooklyn 5
Cape Town 5
Dhaka 5
Hải Dương 5
Manchester 5
Nairobi 5
Piscataway 5
Poplar 5
Porto Alegre 5
Salvador 5
Santo André 5
Seattle 5
Toronto 5
Zurich 5
Abidjan 4
Atlanta 4
Baku 4
Bishkek 4
Boardman 4
Bogotá 4
Brasília 4
Brescia 4
Caivano 4
Campinas 4
Campo Grande 4
Caracas 4
Chai Wan 4
Draper 4
Gainesville 4
Ha Kwai Chung 4
Hillsboro 4
Hortolândia 4
Houston 4
Totale 3.275
Nome #
A novel potent class I HDAC inhibitor reverses the STAT4/p66Shc apoptotic defect in B cells from chronic lymphocytic leukemia patients 346
Development of selective sigma-1 receptor ligands with antiallodynic activity: A focus on piperidine and piperazine scaffolds 333
Biostimulants for Sustainable Food Production: Effects of Wood Distillate to Fortify Chickpea Flour for Development of Functional Bakery Products 237
Synthesis and biological investigation of peptidomimetic SARS‐CoV‐2 main protease inhibitors bearing quinoline‐based heterocycles at P3 173
Discovery of p-Trifluoromethylbenzohydrazide Derivatives as Potent Antiviral Agents against Monkeypox Virus 157
Novel N-normetazocine derivatives with opioid Agonist/Sigma-1 receptor antagonist profile as potential analgesics in inflammatory pain 149
Dual Sigma-1 receptor antagonists and hydrogen sulfide-releasing compounds for pain treatment: design, synthesis, and pharmacological evaluation 144
Design, synthesis and biological evaluation of novel aminopropylcarboxamide derivatives as sigma ligands 136
Tuning properties for blood-brain barrier permeation: a statistics-based analysis 136
Combination of heme oxygenase-1 inhibition and sigma receptor modulation for anticancer activity 125
Structural and molecular insight into Piperazine and Piperidine derivatives as Histamine H3 and Sigma-1 receptor antagonists with promising antinociceptive properties 124
Cytotoxicity profiles and neuroprotective properties of the novel ifenprodil analogues as sigma ligands 122
Development of a Sigma-2 Receptor affinity filter through a Monte Carlo based QSAR analysis 116
Morphing of ibogaine: A successful attempt into the search for sigma-2 receptor ligands 116
Discovery of AD258 as a Sigma Receptor Ligand with Potent Antiallodynic Activity 116
Unlocking the potential of biostimulants in sustainable agriculture: Effect of wood distillate on the nutritional profiling of apples 115
Designing drugs optimized for both blood–brain barrier permeation and intra-cerebral partition 115
Correction to “Nitric Oxide Photo-Donor Hybrids of Ciprofloxacin and Norfloxacin: A Shift in Activity from Antimicrobial to Anticancer Agents” 112
Discovery and computational studies of piperidine/piperazine-based compounds endowed with sigma receptor affinity 112
Design, Synthesis, and Cytotoxic Assessment of New Haloperidol Analogues as Potential Anticancer Compounds Targeting Sigma Receptors 112
(+)-Methyl (1R,2S)-2-{[4-(4-Chlorophenyl)-4-hydroxypiperidin-1-yl]methyl}-1-phenylcyclopropanecarboxylate [(+)-MR200] derivatives as potent and selective sigma receptor ligands: stereochemistry and pharmacological properties 112
Discovery of first novel sigma/HDACi dual-ligands with a potent in vitro antiproliferative activity 110
Discovery, affinity maturation and multimerization of small molecule ligands against human tyrosinase and tyrosinase-related protein 1 109
Dual Piperidine-Based Histamine H3 and Sigma-1 Receptor Ligands in the Treatment of Nociceptive and Neuropathic Pain 107
Comprehensive data on a 2D-QSAR model for Heme Oxygenase isoform 1 inhibitors 107
Nitric oxide photo-donor hybrids of ciprofloxacin and norfloxacin: a shift in activity from antimicrobial to anticancer agents 105
Novel N-Substituted benzomorphan-based compounds: from MOR-agonist/DOR-antagonist to biased/unbiased MOR agonists 104
New Insights into the Opioid Analgesic Profile of cis-(−)-N-Normetazocine-derived Ligands 101
Exploiting the power of stereochemistry in drug action: 3-[(2S,6S,11S)-8-Hydroxy-6,11-dimethyl-1,4,5,6-tetrahydro-2,6-methano-3-benzazocin-3(2H)-yl]-N-phenylpropanamide as potent Sigma-1 receptor antagonist 99
Synthesis, computational insights, and evaluation of novel sigma receptors ligands 97
Structure–Property Optimization of a Series of Imidazopyridines for Visceral Leishmaniasis 97
Adipocyte fatty acid binding protein 4 (FABP4) inhibitors. A comprehensive systematic review 92
Exploring Structural Requirements for Sigma-1 Receptor Linear Ligands: Experimental and Computational Approaches 88
Uncovering a Mutation-Independent Therapeutic Strategy against Inherited Retinal Diseases: Development of Class I HDAC/LSD1 Hybrid Inhibitors 87
Targeting heme Oxygenase-1 with hybrid compounds to overcome Imatinib resistance in chronic myeloid leukemia cell lines 86
Identification of Potentially Potent Heme Oxygenase 1 Inhibitors through 3D-QSAR Coupled to Scaffold-Hopping Analysis 84
Haloperidol Metabolite II Valproate Ester (S)-(-)-MRJF22: preliminary studies as a potential multifunctional agent against uveal melanoma 84
Molecular modeling studies of pseudouridine isoxazolidinyl nucleoside analogues as potential inhibitors of the pseudouridine 5ʹ-monophosphate glycosidase 83
Sigma receptor ligands carrying a nitric oxide donor nitrate moiety: synthesis, In silico, and biological evaluation 82
Sigma-2 receptor ligands QSAR model dataset 81
H2S releasing molecules in pharmaceutical development 77
Recent advances in drug discovery of phototherapeutic non-porphyrinic anticancer agents 71
Open Source Antibiotics: Simple Diarylimidazoles Are Potent against Methicillin-Resistant Staphylococcus aureus 71
Heme Oxygenase Database (HemeOxDB) and QSAR Analysis of Isoform 1 Inhibitors 68
Novel Sigma-1 receptor antagonists: From opioids to small molecules: What is new? 65
Repurposing of human kinase inhibitors in neglected protozoan diseases 65
Hyphenated 3D-QSAR statistical model-scaffold hopping analysis for the identification of potentially potent and selective sigma-2 receptor ligands 61
Novel Sigma Receptors Ligands-Nitric Oxide Photodonor: Molecular Hybrids for Double-Targeted Antiproliferative Effect 51
Synthesis and evaluation of haloperidol metabolite II prodrugs as anticancer agents 42
Totale 5.582
Categoria #
all - tutte 15.273
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.273


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202363 0 0 0 0 0 0 0 0 0 0 62 1
2023/2024159 1 0 0 5 0 3 18 2 5 0 18 107
2024/20251.403 39 27 130 45 138 120 39 61 191 79 95 439
2025/20263.780 255 511 510 582 506 96 454 129 130 234 111 262
2026/2027177 114 63 0 0 0 0 0 0 0 0 0 0
Totale 5.582